TY - JOUR
T1 - Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia
AU - Allen, J. M.
AU - Ferrier, I. N.
AU - Roberts, G. W.
AU - Cross, A. J.
AU - Adrian, T. E.
AU - Crow, T. J.
AU - Bloom, S. R.
PY - 1984/6
Y1 - 1984/6
N2 - Concentrations of neuropeptide Y (NPY) have been determined in 12 areas of control brains and compared to those found in brains from patients with Alzheimer's type dementia (ATD). The distribution of NPY in the control brains was compared with those reported previously. Highest concentrations were identified in the subcortical structures, in particular, nucleus accumbens (203 ± 21.7 pmol/g), amygdala (136.7 ± 15.8 pmol/g), and substantia innominata (109.0 ± 12.6 pmol/g). A significant elevation in NPY concentrations was identified in the region of the substantia innominata of Alzheimer brains (controls: 109.0 ± 12.6 pmol/g, ATD: 206 ± 28.2 pmol/g, P < 0.001). This change in NPY concentration was similar to the increase in somatostatin concentration in this region of ATD brain. In contrast, although cortical concentrations of somatostatin were reduced in ATD, no change was found in the concentrations of NPY in the 4 regions of cerebral cortex and the remaining subcortical areas examined.
AB - Concentrations of neuropeptide Y (NPY) have been determined in 12 areas of control brains and compared to those found in brains from patients with Alzheimer's type dementia (ATD). The distribution of NPY in the control brains was compared with those reported previously. Highest concentrations were identified in the subcortical structures, in particular, nucleus accumbens (203 ± 21.7 pmol/g), amygdala (136.7 ± 15.8 pmol/g), and substantia innominata (109.0 ± 12.6 pmol/g). A significant elevation in NPY concentrations was identified in the region of the substantia innominata of Alzheimer brains (controls: 109.0 ± 12.6 pmol/g, ATD: 206 ± 28.2 pmol/g, P < 0.001). This change in NPY concentration was similar to the increase in somatostatin concentration in this region of ATD brain. In contrast, although cortical concentrations of somatostatin were reduced in ATD, no change was found in the concentrations of NPY in the 4 regions of cerebral cortex and the remaining subcortical areas examined.
KW - Alzheimer's type dementia
KW - Choline acetyl transferase
KW - Neuropeptide Y
KW - Somatostatin
UR - http://www.scopus.com/inward/record.url?scp=0021233551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021233551&partnerID=8YFLogxK
U2 - 10.1016/0022-510X(84)90180-1
DO - 10.1016/0022-510X(84)90180-1
M3 - Article
C2 - 6147394
AN - SCOPUS:0021233551
SN - 0022-510X
VL - 64
SP - 325
EP - 331
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 3
ER -